Eiger Biopharma Stock Price (NASDAQ:EIGR)

Add to My Stocks
$13 $0.1 (0.76%) EIGR stock closing price May 25, 2018 (Closing)
Prev Close* : $13.1
Market Cap:
$138.08M
Day Low: $12.81
52 Week Low: $6.10
Open: $13
Volume: -
Day High: $13.5
52 Week High: $18.00
Dividend:
0.00

Latest Stock Market News

Latest Articles

Eiger Biopharma News - From Partners

EIGR Stockcharts

View EIGR PE ratio, PS ratio stocks charts and compare with peers.
EIGR Chart
Note: Compare Eiger Biopharma stock price history with the index and industry peers.

Eiger Biopharma Valuation

PE ratio
(price earnings ratio)
-999.0000
PS ratio (
price to sales ratio
)
-999.0000
PB ratio (
price to book ratio
)
-999.0000

Eiger Biopharma Returns

ROE
(return on equity)

Eiger Biopharma Financial Ratios

Asset Turnover
Receivables Turnover
Debt to Equity
Dividend Yield
-999.0000

EIGR Industry Peers

Company Price Change (%)
Eyepoint Pharma (EYPT)2.010.06 (2.9%)
Leap Therapeutc (LPTX)8.540.06 (0.7%)
Arrowhead Pharma (ARWR)10.050.28 (2.87%)
Alnylam Pharma (ALNY)99.981.01 (1.02%)
United Therapeutics (UTHR)103.61.13 (1.08%)
Merck (MRK)59.090.04 (0.07%)
Johnson & Johnson (JNJ)121.470.78 (0.64%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Mirati Therapeutics (MRTX)44.355.3 (13.57%)
Fortress Biotech (FBIO)3.450.32 (10.22%)
Cara Therapeutics (CARA)17.021.46 (9.38%)
Keryx Biopharma (KERX)5.250.25 (5%)
BioMarin Pharma (BMRN)92.494.21 (4.77%)
Ultragenyx Pharma (RARE)67.312.81 (4.36%)
Horizon Pharma (HZNP)16.170.65 (4.19%)
Top gainers from Medical-Biomed-Genetics industry
* As of May 25, 2018
CompanyPriceChange (%)
Vital Therapies (VTL)5.70.45 (7.32%)
Verastem (VSTM)5.380.35 (6.11%)
MiMedx (MDXG)8.350.52 (5.86%)
Momenta Pharma (MNTA)23.051.3 (5.34%)
Chromadex (CDXC)3.440.17 (4.71%)
SANGAMO THERAP (SGMO)15.60.7 (4.29%)
BioDelivery Sciences (BDSI)2.40.1 (4%)
Top losers from Medical-Biomed-Genetics industry
* As of May 25, 2018

Eiger Biopharmaceuticals Inc Stock News - Partner Headlines

Eiger Biopharma Financial Statements

income statement20172016201520142013
Net Sales or Revenues-----
Net Income-42.44M-47.08M-44.41M-33.85M-19.99M
Total Operating Expense41.51M46.11M42.17M33.01M19.95M
View Eiger Biopharma income statement
balance sheet20172016201520142013
Total Assets42.88M60.73M33.88M89.11M21.15M
Total Liabilities20.36M20.01M2.33M17M6.59M
Shareholders Equity22.52M40.72M31.55M72.1M14.55M
View Eiger Biopharma balance sheet
cash flow statement20172016201520142013
Net Increase (Decrease) in Assets Liabilities-0.32M1.71M-2.12M-1.94M
Net Cash from (used by) Operating Activities-38.37M-37.97M-41.09M-29.25M-16.19M
Increase (Decrease) in Prop Plant And Equipment-0.04M-0.05M--0.73M-0.08M
View Eiger Biopharma cash flow statement

Eiger Biopharma Stock Message Board

Eiger Biopharma stock price ended the last trading day at $13. Stock price or share price can be used to find the total market value of a company. Eiger Biopharma market cap stands at $138.08M as of May 25, 2018. A value investor must look at the fundamentals of a stock, and perform Eiger Biopharma valuation, even though in the short-term, sentiment and current breaking news might affect Eiger Biopharma stock price.

For recognizing and analyzing the real performance of Eiger Biopharma stock, it is a standard practise to adjust historical stock prices to remove gaps caused by stock splits, dividends and distributions. 304,937 shares were traded with a closing stock price of $13 as of May 25, 2018, as can be seen from Eiger Biopharma stock quote. One can view Eiger Biopharma stock chart to follow the stock price trend. Dividends are usually paid by large stable companies, and typically not by those which are in their rapid growth stages. A company's continuing success is indicated by a steadily increasing dividend payout. Eiger Biopharma dividend per share was 0.00 during the last quarter. To check the historical stock price movement, all time high, and all time low of EIGR, view Eiger Biopharma stock price history.